These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16785278)

  • 1. The role of emission tomography in pharmacokinetic and pharmacodynamic studies in clinical psychopharmacology.
    Malizia AL
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):100-7. PubMed ID: 16785278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of neuroreceptor imaging to psychiatry research.
    Smith GS; Koppel J; Goldberg S
    Psychopharmacol Bull; 2003; 37(4):26-65. PubMed ID: 15131516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacology--in vivo neurochemistry and pharmacology.
    Grasby P; Malizia A; Bench C
    Br Med Bull; 1996 Jul; 52(3):513-26. PubMed ID: 8949254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging with SPECT as a tool for drug development.
    Gomes CM; Abrunhosa AJ; Ramos P; Pauwels EK
    Adv Drug Deliv Rev; 2011 Jun; 63(7):547-54. PubMed ID: 20933557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET versus SPECT: strengths, limitations and challenges.
    Rahmim A; Zaidi H
    Nucl Med Commun; 2008 Mar; 29(3):193-207. PubMed ID: 18349789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nuclear medicine imaging in neurodegenerative dementias].
    Gratz S; Hahn U; Kaiser JW; Jarnig M; Schwarz J; Förstl H
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S5-7. PubMed ID: 18437639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPET in psychopharmacology.
    Moresco RM; Fazio F
    Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):205-14. PubMed ID: 16010255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular imaging in evaluation of in vivo behavior of drugs].
    Saji H
    Nihon Rinsho; 2007 Feb; 65(2):363-9. PubMed ID: 17302285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET & SPECT instrumentation.
    Spanoudaki VC; Ziegler SI
    Handb Exp Pharmacol; 2008; (185 Pt 1):53-74. PubMed ID: 18626798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo molecular imaging biomarkers: clinical pharmacology's new "PET"?
    Nutt R; Vento LJ; Ridinger MH
    Clin Pharmacol Ther; 2007 Jun; 81(6):792-5. PubMed ID: 17505491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-photon emission computed tomography/computed tomography in lung cancer and malignant lymphoma.
    Schillaci O
    Semin Nucl Med; 2006 Oct; 36(4):275-85. PubMed ID: 16950145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial viability testing in patients with severe left ventricular dysfunction by SPECT and PET.
    Demirkol MO
    Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():60-70. PubMed ID: 19028637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of vascular prosthesis infection: PET or SPECT?
    Burroni L; D'Alessandria C; Signore A
    J Nucl Med; 2007 Aug; 48(8):1227-9. PubMed ID: 17673424
    [No Abstract]   [Full Text] [Related]  

  • 15. [Strategy for development of imaging biomarkers].
    Ishiwata K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective neuroimaging in vivo.
    Smith DF; Jakobsen S
    Eur Neuropsychopharmacol; 2007 Jul; 17(8):507-22. PubMed ID: 17368004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and validation of the body edge in low count emission tomography images.
    Barnden LR; Dickson J; Hutton BF
    Comput Methods Programs Biomed; 2006 Dec; 84(2-3):153-61. PubMed ID: 16978729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of SPECT in a time of PET.
    Jansen FP; Vanderheyden JL
    Nucl Med Biol; 2007 Oct; 34(7):733-5. PubMed ID: 17921025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using positron emission tomography to facilitate CNS drug development.
    Lee CM; Farde L
    Trends Pharmacol Sci; 2006 Jun; 27(6):310-6. PubMed ID: 16678917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.